Literature DB >> 1667283

Depression of miniature endplate potential frequency by acetylcholine and its analogues in frog.

E E Nikolsky1, E A Bukharaeva, E G Strunsky, F Vyskocil.   

Abstract

1. Acetylcholine (ACh), 7.5 x 10(-5) M, and carbachol, 5 x 10(-6) M (CCh) depressed the frequency of miniature endplate potentials (m.e.p.ps) in the frog (Rana temporaria) sartorius neuromuscular junction with active acetylcholinesterase to about 50-55% of the controls. 2. A similar depression was produced by the nicotinic agonists, nicotine, suberyldicholine and tetramethylammonium. 3. The muscarinic agonists, oxotremorine, methylfurmethide and methacholine were without effect on m.e.p.p. frequency. The muscarinic antagonist, atropine and the nicotinic antagonist, (+)-tubocurarine, had no effect on the depression of m.e.p.p. frequency evoked by CCh. 4. The ganglionic blockers, benzhexonium and IEM-1119, were also without effect on the CCh-evoked depression of m.e.p.p. frequency. 5. Pretreatment of muscles with anticholinesterases did not prevent the CCh-induced drop in m.e.p.p. frequency. 6. The effect of CCh was proportionally the same as in the controls in preparations where the m.e.p.p. frequency was changed by elevation of K+ and in the presence of theophylline, noradrenaline, dibutyryl adenosine 3':5'-cyclic monophosphate (db cyclic AMP) and db cyclic GMP. 7. An inhibitor of Na+,K(+)-ATPase, ouabain, 5 x 10(-5) mol l-1, prevented or reversed the depression of m.e.p.p. frequency by CCh. However, the depression was present in a nominally K(+)-free medium. Insulin and adrenaline, which are considered to be Na+,K(+)-ATPase activators, were without effect on depression of m.e.p.p. frequency. 8. The depression of m.e.p.p. frequency by 5 x 10(-6) M CCh was the same at temperatures between 5 and 30 degrees C with a Q10 near to 1.0. When threshold amounts of CCh were used (6 x 10-7 and 3 x 10-7 M), the depression was less at higher temperatures.9. The receptive structures responsible for the CCh (or ACh)-evoked depression of m.e.p.p. frequency differ pharmacologically from muscarinic, nicotinic ganglionic and neuromuscular junction ACh-receptors as well as from the synaptic cholinesterase, in contrast to previous reports (Duncan & Publicover, 1979).The low temperature-dependence points to the possibility that physical rather than biochemical processes are limiting in this presynaptic effect of cholinomimetics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667283      PMCID: PMC1908837          DOI: 10.1111/j.1476-5381.1991.tb12544.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  The effects of nerve terminal activity on non-quantal release of acetylcholine at the mouse neuromuscular junction.

Authors:  H Zemková; F Vyskocil; C Edwards
Journal:  J Physiol       Date:  1990-04       Impact factor: 5.182

Review 2.  The role of cyclic-3',5'-AMP in responses to catecholamines and other hormones.

Authors:  E W Sutherland; G A Robison
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

Review 3.  The biophysical pharmacology of calcium-dependent acetylcholine secretion.

Authors:  E M Silinsky
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

4.  Fractionation of protein components of plasma membranes from the electric organ of Torpedo marmorata.

Authors:  L Elfman; E Heilbronn; P L Jørgensen
Journal:  Biochim Biophys Acta       Date:  1982-12-22

5.  Prejunctional effects of anticholinesterase drugs at the endplate: mediated by presynaptic acetylcholine receptors or by postsynaptic potassium efflux?

Authors:  R Hohlfeld; R Sterz; K Peper
Journal:  Pflugers Arch       Date:  1981-09       Impact factor: 3.657

6.  Anion permeability of motor nerve terminals.

Authors:  D A Saint; J G McLarnon; D M Quastel
Journal:  Pflugers Arch       Date:  1987-07       Impact factor: 3.657

7.  Choline inhibits acetylcholine release via presynaptic muscarine receptors.

Authors:  H Kilbinger; R Kruel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

8.  Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction.

Authors:  S Thesleff; J Molgó; H Lundh
Journal:  Brain Res       Date:  1983-03-28       Impact factor: 3.252

9.  Relation between subsynaptic receptor blockade and response to quantal transmitter at the mouse neuromuscular junction.

Authors:  P Pennefather; D M Quastel
Journal:  J Gen Physiol       Date:  1981-09       Impact factor: 4.086

10.  Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles.

Authors:  C Haimann; F Torri-Tarelli; R Fesce; B Ceccarelli
Journal:  J Cell Biol       Date:  1985-11       Impact factor: 10.539

View more
  3 in total

1.  The effects of carbachol on the proximal and distal parts of frog motor nerve endings.

Authors:  R A Giniatullin; D V Samigullin; S N Grishin; E A Bukharaeva
Journal:  Neurosci Behav Physiol       Date:  2002 Nov-Dec

Review 2.  Early postdenervation depolarization is controlled by acetylcholine and glutamate via nitric oxide regulation of the chloride transporter.

Authors:  Frantisek Vyskocil
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

3.  Temperature effect on carbachol-induced depression of spontaneous quantal transmitter release in frog neuromuscular junction.

Authors:  E G Strunsky; M D Borisover; E E Nikolsky; F Vyskocil
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.